CGIX News and Press, Cancer Genetics Inc. From 11/02/20

Rutherford, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics” or “the Company”), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced the closing of its previously announce...

Gainers: Universal Security Instruments (UUU) +69%.Polar Power (POLA) +37%.Rekor Systems (REKR) +35%.Entercom Communications (ETM) +33%.Pinterest (PINS) +29%.Inphi (IPHI) +28%.Forte Biosciences (FBRX) +21%.Meta Financial Group (CASH) +19%.Novus Therapeutics (NVUS) +18%.Dig...

Gainers: vTv Therapeutics (VTVT) +22%, Forte Biosciences (FBRX) +20%, Penumbra (PEN) +14%, Cellect Biotechnology (APOP) +10%, Inari Medical (NARI) +10%.Losers: Tricida (TCDA) -52%, Cancer Genetics (CGIX) -34%., Constellation Pharmaceutica...

Due to demand, Cancer Genetics (CGIX) announces that the underwriter has agreed to increase the size of its previous public offering of 1,363,637 common shares (from ~909.1K) at $2.20/share, for expected gross proceeds of ~$3M.Underwriter's over-allotment is an additional 204,545 shares. Net ...

Cancer Genetics (CGIX) -38% after upsized public offering.Tricida (TCDA) -29% after updating its end-of-review Type A meeting with the FDA.Miragen Therapeutics (MGEN) -15%.Nokia (NOK) -16% after Q3 earnings results.CPS Technologies (CPSH) -14% after Q3 earni...

Rutherford, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics”), a leader in drug discovery and preclinical oncology and immuno-oncology services, announced today that, due to demand, the underwriter has agreed to increase the size ...

Rutherford, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics”), a leader in in drug discovery and preclinical oncology and immuno-oncology services, announced today that it has entered into an underwriting agreement with H.C. Wainw...

NEW YORK, NY / ACCESSWIRE / October 13, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sal...

Gainers: Organovo Holdings (ONVO) +12%, Lantern Pharma (LTRN) +11%, Cancer Genetics (CGIX) +10%, American Well (AMWL) +10%, Immuron (IMRN) +9%.Losers: Avenue Therapeutics ATXI -57%, Zynex ZYXI -27%, Fortress Biotech FBIO -22%, &...

NEW YORK, NY / ACCESSWIRE / October 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Cancer Genetics, Inc. (NASDAQ:CGIX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Stemo...